Kaori Ito

Toyoake, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Correction: Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Correction: Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Journal: Journal of pharmaceutical health care and sciences

Published: July 18, 2026

Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study.

Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study.

Journal: Cureus

Published: October 30, 2025

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Journal: Journal of pharmaceutical health care and sciences

Published: October 01, 2025

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study.

Journal: Journal of pharmaceutical health care and sciences

Published: October 01, 2025

A multicenter retrospective study evaluating the effect of proton pump inhibitors on adjuvant tegafur-uracil/leucovorin efficacy for stage II-III colorectal cancer.

A multicenter retrospective study evaluating the effect of proton pump inhibitors on adjuvant tegafur-uracil/leucovorin efficacy for stage II-III colorectal cancer.

Journal: Scientific reports

Published: October 17, 2024

Comparing Injection Site Reactions of Aprepitant and Fosaprepitant in Gynecologic Cancer Chemotherapy.

Comparing Injection Site Reactions of Aprepitant and Fosaprepitant in Gynecologic Cancer Chemotherapy.

Journal: In vivo (Athens, Greece)

Published: April 23, 2024

Implementation of support meetings for patients undergoing outpatient chemotherapy by a multidisciplinary cancer team.

Implementation of support meetings for patients undergoing outpatient chemotherapy by a multidisciplinary cancer team.

Journal: Fujita medical journal

Published: April 09, 2024

Cytomegalovirus Occurrence and Time-to-onset Analysis Under Bendamustine With Anti-CD20 Antibodies Using the JADER Database.

Cytomegalovirus Occurrence and Time-to-onset Analysis Under Bendamustine With Anti-CD20 Antibodies Using the JADER Database.

Journal: In vivo (Athens, Greece)

Published: November 22, 2023

Effect of Liver Dysfunction on S-1 Therapy Induced Adverse Effects: A Retrospective Cohort Study.

Effect of Liver Dysfunction on S-1 Therapy Induced Adverse Effects: A Retrospective Cohort Study.

Journal: In vivo (Athens, Greece)

Published: October 12, 2023

Factors Affecting the Comprehension of Outpatients Receiving Cancer Chemotherapy.

Factors Affecting the Comprehension of Outpatients Receiving Cancer Chemotherapy.

Journal: Biological & pharmaceutical bulletin

Published: March 01, 2023

Impact of Lumbar Surgery on Pharmacological Treatment for Patients with Lumbar Spinal Canal Stenosis: A Single-Center Retrospective Study.

Impact of Lumbar Surgery on Pharmacological Treatment for Patients with Lumbar Spinal Canal Stenosis: A Single-Center Retrospective Study.

Journal: Journal of clinical medicine

Published: February 15, 2023

Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study.

Impact of prior bevacizumab therapy on the incidence of ramucirumab-induced proteinuria in colorectal cancer: a multi-institutional cohort study.

Journal: International journal of clinical oncology

Published: January 17, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026